vs
Side-by-side financial comparison of Liberty Energy Inc. (LBRT) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $1.0B, roughly 1.1× Liberty Energy Inc.). Liberty Energy Inc. runs the higher net margin — 2.2% vs -127.8%, a 130.0% gap on every dollar of revenue. On growth, Liberty Energy Inc. posted the faster year-over-year revenue change (4.5% vs -2.5%). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -6.2%).
Liberty Energy Inc. is a North American energy services provider specializing in hydraulic fracturing and well completion solutions for oil and gas operators. It serves clients across major U.S. shale basins, offering low-emission equipment and tailored support to optimize well productivity.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
LBRT vs PRGO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $1.1B |
| Net Profit | $22.6M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | 2.2% | -116.0% |
| Net Margin | 2.2% | -127.8% |
| Revenue YoY | 4.5% | -2.5% |
| Net Profit YoY | 64.8% | -3093.9% |
| EPS (diluted) | $0.14 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $1.1B | ||
| Q3 25 | $947.4M | $1.0B | ||
| Q2 25 | $1.0B | $1.1B | ||
| Q1 25 | $977.5M | $1.0B | ||
| Q4 24 | $943.6M | $1.1B | ||
| Q3 24 | $1.1B | $1.1B | ||
| Q2 24 | $1.2B | $1.1B |
| Q1 26 | $22.6M | — | ||
| Q4 25 | $13.7M | $-1.4B | ||
| Q3 25 | $43.1M | $7.5M | ||
| Q2 25 | $71.0M | $-8.4M | ||
| Q1 25 | $20.1M | $-6.4M | ||
| Q4 24 | $51.9M | $-44.4M | ||
| Q3 24 | $73.8M | $-21.0M | ||
| Q2 24 | $108.4M | $-108.4M |
| Q1 26 | — | — | ||
| Q4 25 | 20.6% | 32.6% | ||
| Q3 25 | 18.7% | 36.1% | ||
| Q2 25 | 22.1% | 34.4% | ||
| Q1 25 | 22.1% | 37.6% | ||
| Q4 24 | 21.4% | 33.9% | ||
| Q3 24 | 26.2% | 37.2% | ||
| Q2 24 | 27.9% | 37.0% |
| Q1 26 | 2.2% | — | ||
| Q4 25 | 1.9% | -116.0% | ||
| Q3 25 | -0.3% | 7.0% | ||
| Q2 25 | 3.6% | 4.3% | ||
| Q1 25 | 1.9% | 4.5% | ||
| Q4 24 | 2.6% | 10.0% | ||
| Q3 24 | 9.4% | 7.4% | ||
| Q2 24 | 12.2% | -2.5% |
| Q1 26 | 2.2% | — | ||
| Q4 25 | 1.3% | -127.8% | ||
| Q3 25 | 4.5% | 0.7% | ||
| Q2 25 | 6.8% | -0.8% | ||
| Q1 25 | 2.1% | -0.6% | ||
| Q4 24 | 5.5% | -3.9% | ||
| Q3 24 | 6.5% | -1.9% | ||
| Q2 24 | 9.3% | -10.2% |
| Q1 26 | $0.14 | — | ||
| Q4 25 | $0.08 | $-10.23 | ||
| Q3 25 | $0.26 | $0.05 | ||
| Q2 25 | $0.43 | $-0.06 | ||
| Q1 25 | $0.12 | $-0.05 | ||
| Q4 24 | $0.31 | $-0.32 | ||
| Q3 24 | $0.44 | $-0.15 | ||
| Q2 24 | $0.64 | $-0.79 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $699.1M | — |
| Total DebtLower is stronger | $7.1M | — |
| Stockholders' EquityBook value | $1.9B | $2.9B |
| Total Assets | $4.4B | $8.5B |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $699.1M | — | ||
| Q4 25 | $27.6M | — | ||
| Q3 25 | $13.5M | $432.1M | ||
| Q2 25 | $19.6M | $454.2M | ||
| Q1 25 | $24.1M | $409.9M | ||
| Q4 24 | $20.0M | $558.8M | ||
| Q3 24 | $23.0M | $1.5B | ||
| Q2 24 | $30.0M | $542.8M |
| Q1 26 | $7.1M | — | ||
| Q4 25 | $246.6M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $190.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $1.9B | — | ||
| Q4 25 | $2.1B | $2.9B | ||
| Q3 25 | $2.1B | $4.4B | ||
| Q2 25 | $2.0B | $4.5B | ||
| Q1 25 | $2.0B | $4.4B | ||
| Q4 24 | $2.0B | $4.3B | ||
| Q3 24 | $2.0B | $4.6B | ||
| Q2 24 | $1.9B | $4.5B |
| Q1 26 | $4.4B | — | ||
| Q4 25 | $3.6B | $8.5B | ||
| Q3 25 | $3.5B | $10.1B | ||
| Q2 25 | $3.4B | $10.1B | ||
| Q1 25 | $3.4B | $9.8B | ||
| Q4 24 | $3.3B | $9.6B | ||
| Q3 24 | $3.3B | $11.2B | ||
| Q2 24 | $3.2B | $10.4B |
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.12× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.10× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | 13.1% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $195.4M | $175.4M | ||
| Q3 25 | $51.5M | $51.7M | ||
| Q2 25 | $170.6M | $75.9M | ||
| Q1 25 | $192.1M | $-64.5M | ||
| Q4 24 | $177.3M | $312.6M | ||
| Q3 24 | $244.5M | $42.2M | ||
| Q2 24 | $248.2M | $9.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-10.0M | $148.6M | ||
| Q3 25 | $-67.2M | $29.8M | ||
| Q2 25 | $33.1M | $56.7M | ||
| Q1 25 | $58.2M | $-90.0M | ||
| Q4 24 | $-26.2M | $274.9M | ||
| Q3 24 | $77.9M | $15.1M | ||
| Q2 24 | $112.2M | $-18.9M |
| Q1 26 | — | — | ||
| Q4 25 | -1.0% | 13.4% | ||
| Q3 25 | -7.1% | 2.9% | ||
| Q2 25 | 3.2% | 5.4% | ||
| Q1 25 | 6.0% | -8.6% | ||
| Q4 24 | -2.8% | 24.2% | ||
| Q3 24 | 6.8% | 1.4% | ||
| Q2 24 | 9.7% | -1.8% |
| Q1 26 | 13.1% | — | ||
| Q4 25 | 19.8% | 2.4% | ||
| Q3 25 | 12.5% | 2.1% | ||
| Q2 25 | 13.2% | 1.8% | ||
| Q1 25 | 13.7% | 2.4% | ||
| Q4 24 | 21.6% | 3.3% | ||
| Q3 24 | 14.6% | 2.5% | ||
| Q2 24 | 11.7% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | 14.28× | — | ||
| Q3 25 | 1.20× | 6.89× | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 9.55× | — | ||
| Q4 24 | 3.42× | — | ||
| Q3 24 | 3.31× | — | ||
| Q2 24 | 2.29× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LBRT
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
